Literature DB >> 16170833

Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy.

Kylie A McLachlan1, David O'Neal, Alicia Jenkins, Frank P Alford.   

Abstract

BACKGROUND: The role of adiponectin, tumour necrosis factor alpha (TNFalpha), leptin and C-reactive protein in the insulin resistance of pregnancy is not clear. We measured their levels in women with gestational diabetes (GDM) and in controls, during and after pregnancy, and related them to insulin secretion and action.
METHODS: Nineteen women with GDM and 19 BMI-matched healthy pregnant women underwent intravenous glucose tolerance tests in the third trimester of pregnancy and 4 months postpartum to determine insulin sensitivity (SI) and insulin secretion. Adiponectin, TNFalpha, leptin and high sensitivity CRP (hsCRP) were measured in fasted blood.
RESULTS: Of the circulating factors, only leptin (r = -0.41, p = 0.01) correlated with SI in pregnancy. Leptin and hsCRP levels were elevated in pregnancy compared to postpartum (leptin (mean +/- SEM): 27.8 +/- 2.4 vs 19.3 +/- 2.1 ng/mL, p < 0.001; hsCRP: 5.2 +/- 0.7 vs 3.2 +/- 0.6 mg/L, p < 0.001). Adiponectin levels did not change from pregnancy to postpartum, despite a marked increase in SI. All four factors correlated with SI postpartum (adiponectin: r = 0.38, p = 0.01; TNFalpha: r = -0.48, p = 0.002; Leptin: r = -0.61, p = 0.001; hsCRP: r = -0.48, p = 0.002). TNFalpha correlated inversely with insulin secretion in pregnancy (r = -0.35, p = 0.03) and was significantly higher in the GDM group (2.62 +/- 0.3 vs 1.88 +/- 0.3 pg/mL, p = 0.01) in pregnancy.
CONCLUSION: In our study, the influence of adiponectin, TNFalpha and hsCRP upon SI is overwhelmed by other factors in pregnancy. While leptin and SI correlated in pregnancy, it is unclear whether this represents cause or effect. Finally, TNFalpha may exert an inhibitory effect on insulin secretion in GDM, contributing to the associated hyperglycaemia. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16170833     DOI: 10.1002/dmrr.591

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  52 in total

1.  Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus: The CARDIA study.

Authors:  Erica P Gunderson; Charles P Quesenberry; David R Jacobs; Juanran Feng; Cora E Lewis; Stephen Sidney
Journal:  Am J Epidemiol       Date:  2010-10-07       Impact factor: 4.897

2.  Normal pregnancy- a state of insulin resistance.

Authors:  Amit D Sonagra; Shivaleela M Biradar; Dattatreya K; Jayaprakash Murthy D S
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Authors:  C Kim; C A Christophi; R B Goldberg; L Perreault; D Dabelea; S M Marcovina; X Pi-Sunyer; E Barrett-Connor
Journal:  Diabet Med       Date:  2015-05-29       Impact factor: 4.359

Review 4.  Inflammation in maternal obesity and gestational diabetes mellitus.

Authors:  P Pantham; I L M H Aye; T L Powell
Journal:  Placenta       Date:  2015-04-28       Impact factor: 3.481

Review 5.  Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review.

Authors:  Naomi Achong; Harold David McIntyre; Leonie Callaway
Journal:  Obstet Med       Date:  2014-01-17

6.  Camel whey protein improves lymphocyte function and protects against diabetes in the offspring of diabetic mouse dams.

Authors:  Mohamed H Mahmoud; Gamal Badr; Nashwa A El Shinnawy
Journal:  Int J Immunopathol Pharmacol       Date:  2016-09-30       Impact factor: 3.219

7.  Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy.

Authors:  Luigi Bouchard; Stéphanie Thibault; Simon-Pierre Guay; Marta Santure; Alexandre Monpetit; Julie St-Pierre; Patrice Perron; Diane Brisson
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 19.112

8.  Maternal visfatin concentration in normal pregnancy.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 9.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

10.  Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy.

Authors:  H David McIntyre; Allan M Chang; Leonie K Callaway; David M Cowley; Alan R Dyer; Tatjana Radaelli; Kristen A Farrell; Larraine Huston-Presley; Saeid B Amini; John P Kirwan; Patrick M Catalano
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.